➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Last Updated: August 4, 2020

DrugPatentWatch Database Preview

Ramucirumab - Biologic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for ramucirumab

Tradenames:	1
Patents:	39
Applicants:	1
BLAs:	1
Suppliers: see list	1
Recent Clinical Trials:	See clinical trials for ramucirumab

Recent Clinical Trials for ramucirumab

Identify potential brand extensions & biosimilar entrants

Sponsor	Phase
Sanofi	Phase 2
Emory University	Phase 2
Apices Soluciones S.L.	Phase 2

See all ramucirumab clinical trials

Pharmacology for ramucirumab

Mechanism of Action	VEGFR2 Inhibitors

Patent Text Search: US Patents for ramucirumab

These patents were identified by searching patent claims

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Number	Approval Date	Patent No.	Assignee	Estimated Patent Expiration	Status	Orphan	Source
Eli Lilly And Co	CYRAMZA	ramucirumab	INJECTABLE;INJECTION	125477	001	2014-04-21	Start Trial	PTC Therapeutics, Inc. (South Planfield, NJ)	2024-03-15	RX		search
Eli Lilly And Co	CYRAMZA	ramucirumab	INJECTABLE;INJECTION	125477	001	2014-04-21	Start Trial	PTC Therapeutics, Inc. (South Plainfield, NJ)	2025-03-15	RX		search
Eli Lilly And Co	CYRAMZA	ramucirumab	INJECTABLE;INJECTION	125477	001	2014-04-21	Start Trial	biOasis Technologies, Inc. (Vancouver, British Columbia, unknown)	2031-08-05	RX		search
Eli Lilly And Co	CYRAMZA	ramucirumab	INJECTABLE;INJECTION	125477	001	2014-04-21	Start Trial	biOasis Technologies, Inc. (Richmond, CA)	2033-03-13	RX		search
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Number	>Approval Date	>Patent No.	>Assignee	>Estimated Patent Expiration	>Status	>Orphan	>Source

International Patents for ramucirumab

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
South Korea	101583388	Start Trial
South Korea	20140025375	Start Trial
China	108064283	Start Trial
South Korea	20080097995	Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic

Express Scripts

Merck

Dow

Baxter

Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.